Skip to main content
MIB Agents OsteoBites

MIB Agents OsteoBites

By Ann Graham
Each week, MIB Agents talks with the leaders and innovators in osteosarcoma surgery, research, treatment and advocacy. Questions are taken during the webinar and are included in each podcast. More information is available at www.mibagents.org
Listen on
Where to listen
Apple Podcasts Logo

Apple Podcasts

Breaker Logo

Breaker

Google Podcasts Logo

Google Podcasts

Overcast Logo

Overcast

Pocket Casts Logo

Pocket Casts

RadioPublic Logo

RadioPublic

Spotify Logo

Spotify

Currently playing episode

OsteoBites S1 Ep19: Modeling & Targeting MYC-Driven Osteosarcoma

MIB Agents OsteoBites

1x
OsteoBites Welcomes Junior Board Members to discuss "Four OsteoWarriors' Perspectives".
OsteoBites Welcomes Junior Board Members to discuss "Four OsteoWarriors' Perspectives".   ... Brandon, Charlotte, Kara, and Maeve will be speaking about their experiences as patients and survivors.  Topics include:   📌Life After Osteosarcoma, Brandon Friedman 📌Things I Wish I knew Going Into Treatment, Kara Skrubis 📌What It's Like To Be A Patient On A Clinical Trial, Charlotte Murdoff 📌Connecting After Cancer, Maeve Smart ... Hosted by:   Ann Graham OsteoWarrior and Executive Director of MIB Agents ... 🔗LINKS Osteosarcoma: www.mibagents.org/outrunning OS Clinical Trial Search: www.mibagents.org/physicians-researchers/clinical-trials Ambassador Agents: https://www.mibagents.org/agents/ambassador-agents … What We Do at MIB Agents: PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard ... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 🔗 https://www.mibagents.org​
01:07:26
July 30, 2021
OsteoBites welcomes Dr. Moyez Jiwa to discuss "The Art of Doctoring"
Dr. Jiwa is a practicing General Practitioner, Editor-in-Chief at the Journal Of Health Design, and an Associate Dean and Professor at the Melbourne Clinical School at the University of Notre Dame.    From Dr. Jiwa:  "I bring experience from multiple roles- clinician, researcher, publisher, innovator and leader. What my experience has taught me is that healthcare professionals can achieve great results by focusing on what is in their immediate sphere of influence. In some of my roles, the only thing I got to choose was the color of my tie. Despite that, it has been possible to make a significant contribution to addressing many challenges for patients and providers of healthcare. I enjoy innovating and blogging while practicing the art of medicine."   Hosted by:   Ann Graham OsteoWarrior and Executive Director of MIB Agents Junior Board Members and OsteoWarriors: Mia and Maeve .... LINKS Dr. Jiwa's Email: moyez.jiwa@nd.edu.au   OutRunning Osteosarcoma: www.mibagents.org/outrunning Osteosarcoma Clinical Trial Search: www.mibagents.org/physicians-researchers/clinical-trials … What We Do at MIB Agents: PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard ... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 🔗 https://www.mibagents.org​✨ ✨SUBSCRIBE for all the Osteosarcoma Intel ✨✨
56:16
July 23, 2021
Osteosarcoma OsteoBites S2 Ep 18: Richard Gorlick, MD & Yifei Wang, MD “Antibody Drug Conjugates for Osteosarcoma”
MIB Agents Osteosarcoma OsteoBites S2 Ep 18: Richard Gorlick, MD & Yifei Wang, MD “Antibody Drug Conjugates for Osteosarcoma” ... Guest Information: Richard Gorlick, MD Division Head, Department of Pediatrics Professor, Department of Pediatrics Patient Care Director, Department of Pediatric Sarcoma Research Laboratory Department Chair, ad interim Sarcoma Medical Oncology, Division of Cancer Medicine The University of Texas MD Anderson Cancer Center in Houston, TX Dr. Richard Gorlick is Division Head and Department Chair of Pediatrics, Department Chair ad interim of Sarcoma Medical Oncology in the Division of Cancer Medicine at the MD Anderson Cancer Center, and H. Grant Taylor, M.D., W. W. Sutow, M.D. and Margaret P. Sullivan, M.D. Distinguished Chair in Pediatrics. Dr. Gorlick received his medical degree from Downstate Medical School. He trained at New York-Presbyterian and Memorial Sloan-Kettering Cancer Center, where he began his sarcoma research laboratory and clinical practice. His laboratory is the founding Bone Tumor Resource Laboratory for the Children’s Oncology Group. His molecular pharmacology laboratory is completely focused on osteosarcoma. His laboratory is a member of the NCI-funded Pediatric Preclinical Testing Consortium. Dr. Gorlick is involved in clinical trials, in part, as past chair of the Bone Tumor Disease Committee for COG. He is a past president of the Connective Tissue Oncology Society. Dr. Gorlick has published more than 260 peer-reviewed papers, reviews and book chapters and contributed to MIB Agent’s Testing and Research Directory to help inform a personal treatment plan or to inform research. .... Hosted by: Ann Graham OsteoWarrior and Executive Director of MIB Agents Panelists: Mia Sandino, OsteoWarrior and MIB Junior Board Member Shannon McCormack, OsteoWarrior Sibling and MIB Junior Board Member … The next two weeks we will be taking a break first for July 4th weekend and then a short vacation.   ... LINKS Richard Gorlick, MD RGorlick@MDanderson.org Yeifei Wang, PhD YWang64@MDanderson.org OutRunning Osteosarcoma: www.mibagents.org/outrunning Osteosarcoma Clinical Trial Search:www.mibagents.org/physicians-researchers/clinical-trials ... What We Do at MIB Agents: PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard ... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 🔗 https://www.mibagents.org​ ✨✨SUBSCRIBE for all the Osteosarcoma Intel ✨✨
59:01
June 24, 2021
Osteosarcoma OsteoBites S2 Ep 17: Lara Davis, MD, OHSU Knight Cancer Institute “New Osteosarcoma Clinical Trials”
MIB Agents OsteoBites S2 Ep 17: Lara Davis, MD, OHSU Knight Cancer Institute “New Osteosarcoma Clinical Trials” ... Guest Information: Lara E. Davis, MD Associate Professor Knight Cancer Institute Co-Leader, Translational Oncology Research Program Sarcoma Disease Site Leader Oregon Health & Science University Lara Davis, MD graduated from Wellesley College and then went on to receive her medical degree from OHSU. After training in a dual Internal Medicine and Pediatrics residency program at Harvard, she returned to Portland to complete a combined Adult and Pediatric Oncology fellowship with a focus on Adolescents and Young Adults (AYAs). Dr. Davis joined the faculty at OHSU in 2013, where she is a member of the Knight Cancer Institute with dual appointments in the Division of Medical Oncology and Pediatric Hematology/Oncology. She focuses exclusively on sarcoma in both the clinic and in the laboratory. ... Hosted by: Ann Graham OsteoWarrior and Executive Director of MIB Agents. Panelists: Annika Vallejo - MIB Junior Board Member & Osteosarcoma Sibling Valerie Nguyen - MIB Junior Board Member & Osteosarcoma Sibling … Next week we will be talking with Dr. Richard Gorlick on “Antibody Drug Conjugates”, Dr. Gorlick is the Division Head, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, And Professor, Department of Pediatrics at The University of Texas MD Anderson Cancer Center, he is also a pediatric cancer survivor!  We are looking forward to this conversation ... LINKS OutRunning Osteosarcoma: www.mibagents.org/outrunning OutBidding Osteosarcoma:  www.mibagents.org/outbidding SarcTrials.org More Information on trials discussed Email:  SarcomaSurvivor@ohsu.edu … What We Do at MIB Agents: PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard ... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 🔗 https://www.mibagents.org ✨✨SUBSCRIBE for all the Osteosarcoma Intel ✨✨
47:52
June 17, 2021
Osteosarcoma OsteoBites S2 Ep 16: Julie Lanford, MPH, RD, CSO, LDN on “Nutrition & Cancer; Truths & Myths”
MIB Agents OsteoBites S2 Ep 16:  Julie Lanford, MPH, RD, CSO, LDN a Registered Dietician who will be sharing her expertise on “Nutrition & Cancer Truths & Myths” ... Guest Information: Julie Lanford, MPH, RD, CSO, LDN Wellness Director, Cancer Services Julie received her degree in Biology from North Carolina State University and her Masters in public health nutrition from The University of North Carolina at Chapel Hill. She is a registered dietitian, licensed nutritionist and board-certified specialist in oncology nutrition with 15 years experience.  She can be found on her website CancerDietitian.com  which translates evidence-based nutrition guidelines for everyday life. ... Hosted by: Ann Graham OsteoWarrior and Executive Director of MIB Agents. … Next week we will be talking with Dr. Lara Davis, Associate Professor and Sarcoma Program Director at Knight Cancer Institute at Oregon Health & Science University about NEW OSTEOSARCOMA CLINICAL TRIALS! ... LINKS OutRunning Osteosarcoma: www.mibagents.org/outrunning OutBidding Osteosarcoma:  www.mibagents.org/outbidding Cancer Dietician Website: www.cancerdietician.org Julie Lanford's Email: Julie@cancerdietician.com American Cancer Society: www.cancer.org American Institute for Cancer Research: www.AICR.org Julie's BLOG: LINK Tips for Bowel Regularity: LINK Nutrition During Treatment Tips:  https://www.cancerdietitian.com/tips Webinars: https://www.cancerdietitian.com/webinars … What We Do at MIB Agents: PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard ... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 🔗 https://www.mibagents.org ✨✨SUBSCRIBE for all the Osteosarcoma Intel ✨✨
59:33
June 10, 2021
Osteosarcoma OsteoBites S2 Ep 15: Katie Greenzang, MD, EdM Dana-Farber CI & Harvard Med School “What’s Next? Survivorship"
MIB Agents OsteoBites S2 Ep 15:  Katie Greenzang, MD, EdM from Dana-Farber Cancer Institute/Boston Children’s and Harvard Medical School. Dr. Greenzang will be talking about, “What’s Next?  Osteosarcoma Survivorship”. ... Guest Information: Katie Greenzang, MD, MpH Pediatric oncologist at Dana-Farber/Boston Children’s Hospital Instructor at Harvard Medical School ... Dr. Greenzang completed her pediatrics residency and chief residency at Seattle Children’s Hospital, and her fellowship training in pediatric hematology/oncology at the Dana-Farber Cancer Institute/Boston Children’s Hospital. Her research focuses on patient-provider communication and shared decision-making in children with cancer. She is particularly interested in understanding how families consider the short- and long-term effects of cancer therapies when making treatment decisions, and how we can improve communication about late effects of cancer therapy to help patients and families feel more prepared for cancer survivorship. ... Panelists: Kara Skrubis - MIB Junior Board Members and OsteoWarrior Brandon Friendman - MIB Junior Board Members and OsteoWarrior Maeve Smart - President of MIB Junior Board and OsteoWarrior Ann Graham OsteoWarrior and Executive Director of MIB Agents ... Next week we are taking a break in honor of Memorial Day, the week after we are off as well.  We will be back on June 10th with a MUCH REQUESTED and NEEDED talk with Julie Lanford, on “Nutrition &  Cancer Truths and Myths”.   ... LINKS MIB Agents:  Website Register: https://bit.ly/3fACjuR OutRunning Osteosarcoma:.mibagents.org/outrunning OutBidding Osteosarcoma Contact:  Ann@MIBagents.org
57:13
May 20, 2021
Osteosarcoma OsteoBites S2 Ep 14: Lillian Guenther, MD Dana-Farber CI & Harvard Med School “CRISPR Screening to Identify Novel Genomic Targets"
MIB Agents OsteoBites S2 Ep 14:  Lillian Guenther, MD from Dana-Farber Cancer Institute and Harvard Medical School.  Dr. Guenther will be talking about, “Utilizing CRISPR Screening to Identify Novel Genomic Targets for Osteosarcoma” .... Guest Information: Lillian Guenther, MD Dana Farber Cancer Institute ... Dr. Guenther received her bachelor degree from Brown University and her MD from SUNY Downstate College of Medicine. She spent one year as a Howard Hughes Medical Institute/NIH Research Scholar studying osteosarcoma in Dr. Lee Helman’s laboratory at the National Cancer Institute. Lily is currently an Instructor in Pediatrics at Harvard Medical School and performs research in the lab of Dr. Kimberly Stegmaier. She cares for pediatric cancer patients at Boston Children’s Hospital and in the Jimmy Fund Clinic at Dana-Farber Cancer Institute.  Dr. Guenther was a finalist for our OutSmarting Osteosarcoma Grant.  Our group of osteosarcoma families and Scientific Advisory Team found her research to be truly hopeful and innovative. ... Panelists Matt Allen, 2021 MIB Junior Board Member and Gamer Agents Leadership Team Maeve Smart, OsteoWarrior & 2021 MIB Jr. Board President Amy Woodchecke, Physician’s Assistant and Childhood Cancer Survivor. Ann Graham, OsteoWarrior & Executive Director of MIB Agents. ... Coming up next week, Dr. Katie Greenzang of Dana Farber Cancer Institute and Harvard Medical School on “What’s Next? Osteosarcoma Survivorship” ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... LINKS Register: https://bit.ly/MIBobites OutRunning Osteosarcoma:.mibagents.org/outrunning Dr. Guenther Contact: Lillian_Guenther@dfci.harvard.edu
54:33
May 13, 2021
Osteosarcoma OsteoBites S2 E13: Scott Sauer, PhD on “Preventing Osteosarcoma Lethal Recurrence by Targeting Disseminated Tumor Cells”
MIB Agents OsteoBites S2 Ep 13:  Scott Sauer, PhD on “Preventing Osteosarcoma Lethal Recurrence by Targeting Disseminated Tumor Cells” ... Guest Information: Scott Sauer, PhD Head of Preclinical Discovery Vuja De Sciences, Inc. (www.vujade-life.com) ... Dr. Scott Sauer is a cancer researcher with multidisciplinary training in the fields of cancer biology, immunotherapy and organic chemistry. This diverse expertise provides a unique perspective to address unmet medical needs in cancer recurrence and metastasis. Scott received his PhD at Duke University in organic chemistry and a BS from the University of Maryland. After his PhD work, Dr. Sauer began his postdoctoral training at the Duke University Medical Center. His postdoctoral work was in cancer biology focusing on mechanisms of therapeutic resistance and disease progression. During this time, Scott received numerous postdoctoral awards including his work on the interplay between cancer progression and environmental toxicants. Dr. Sauer’s work was among the top three finalists for our 2021 OutSmarting Osteosarcoma grant. ... Panelists Kara Skrubis, MIB Junior Board Member and OsteoWarrior Amy Woodcheke, Physician’s Assistant and Childhood Cancer Survivor Ann Graham, OsteoWarrior & Executive Director of MIB Agents ... What We Do PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Warrior Mail ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard .... OsteoBites is made possible by listeners like you.  Please consider donating to MIB Agents or be an All Star Agent by being a monthly supporter. Kids are still dying with 40+ year old treatments. Help us MakeItBetter. www.mibagents.org Osteosarcoma Resources:  www.MIBagents.org/contact Dr. Sauer Contact: scott.sauer@vujade-life.com Vuja De Sciences: https://vujade-life.com/ MIB Limited Edition Sunflower Tee & Tank:  https://www.bonfire.com/make-it-better-together/
40:47
May 6, 2021
Osteosarcoma OsteoBites S2 Ep12: Dan Prince, MD, MPH on “Regenerative Surgery for Bone Sarcomas”
MIB Agents OsteoBites S2 Ep12: Dan Prince, MD on “Regenerative Surgery for Bone Sarcomas” ... Guest Information: Daniel Prince, MD, MPH Orthopedic Surgeon Memorial Sloan Kettering Cancer Education (MD): Yale University Medical School Board Certifications: Orthopedic Surgery ... Dr. Prince is an Orthopedic Surgeon from Memorial Sloan Kettering Cancer Center on the “MSK Kids” team, specializing in the care of children, adolescents, and young adults with bone tumors and other diseases of the bone. His research and expertise is in bone regeneration, which relies on the body’s natural abilities to regrow bone after a segment of bone is removed during cancer surgery. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org … What We Do PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Warrior Mail ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard .... OsteoBites is made possible by listeners like you.  Please consider donating to MIB Agents or be a Super Agent by being a monthly supporter. More info on our *New* website, mibagents.org ... 🔗 Kids are still dying with 40+ year old treatments. Help us MakeItBetter. www.mibagents.org Daniel Prince, MD, MPH bit.ly/MIBprince Memorial Sloan Kettering Cancer Center www.mskcc.org OS Resource Kit Order Form www.mibagents.org - click on blue bar at top of page ...
59:57
April 29, 2021
Osteosarcoma OsteoBites S2 Ep 11: Ines Lohse, PhD on “Drug Sensitivity Testing for the Treatment Stratification of Cancer Patients”
MIB Agents OsteoBites S2 Ep 11:  Ines Lohse, PhD on “Drug Sensitivity Testing for the Treatment Stratification of Cancer Patients” ... Guest Information: Ines Lohse, PhD Assistant Scientist University of Miami Center for Therapeutic Innovation ... Dr. Lohse received her PhD from the University of Zurich in 2011. After postdoctoral fellowships at the Princess Margaret Cancer Center (Toronto) and the University of Michigan, Dr. Lohse moved to the University of Miami to focus on the preclinical and early clinical development of novel technology and therapeutic options for cancer patients. The Ex Vivo Drug Sensitivity Testing Platform has been successfully tested in a pilot cohort of patients, including sarcoma.  It is currently in development to transition the platform to clinical routine. ... Panelists Mia Sandino, MIB Junior Board Member and OsteoWarrior Charlotte Murdoff, MIB Junior Board Member and OsteoWarrior Annika Vallejo, MIB Junior Board Member and OsteoWarrior Sibling Ann Graham, OsteoWarrior & Executive Director of MIB Agents. ... Coming up next week is Daniel Prince, MD, MPH Orthopedic Surgeon from Memorial Sloan Kettering Cancer Center on “Regenerative Surgery for Bone Sarcomas”. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites Osteosarcoma Resources:  www.MIBagents.org/contact Dr. Lohse Contact: ixl180@med.miami.edu University of Miami Website: umiamihealth.org/sylvester-comprehensive-cancer-center/research/faculty/ines-lohse-phd
55:01
April 22, 2021
Osteosarcoma OsteoBites S2 Ep 10: Sumit Gupta, MD, PhD, FRCPC “Long Term Mental Health Outcomes in Adolescents and Young Adults with Cancer”
MIB Agents OsteoBites S2 Ep 10:  Sumit Gupta, MD, PhD, FRCPC “Long Term Mental Health Outcomes in Adolescents and Young Adults with Cancer” ... Guest Information: Sumit Gupta, MD, PhD, FRCPC Hospital for Sick Children, Staff Oncologist and Clinician Investigator University of Toronto, Associate Professor Institute for Health Policy, Management and Evaluation, Associate Professor Cancer Research Program at the Institute for Clinical Evaluative Sciences, Adjunct Scientist Dr. Gupta completed a PhD in Clinical Epidemiology from the University of Toronto, during which time he was supported by a CIHR Fellowship Award. He is one of the Assistant Chairs of the Lancet Oncology Commission on Sustainable Pediatric Cancer Care in low and middle income countries. Sumit has worked extensively with pediatric oncologists and policymakers throughout Latin America, the Caribbean, and India. He currently holds grant funding from The Garron Family Cancer Centre, CIHR and the Terry Fox Research Institute.Sumit Gupta, MD, PhD, FRCPC ... Panelists Amy Woodcheke, Physicians Assistant and Childhood Cancer Survivor Mia Sandino, MIB Junior Board Member and OsteoWarriors Ann Graham, OsteoWarrior & Executive Director of MIB Agents ... Coming up next week is Dr. Ines Lohse of University of Miami, Sylvester Comprehensive Cancer Center talking with us about “Drug Sensitivity Testing for the Treatment Stratification of Cancer Patients” ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites Osteosarcoma Resources:  www.MIBagents.org/contact  Link Mentioned on this episode on ASCO BLOG: Addressing the Mental Health Needs of Adolescent and Young Adult Cancer Survivors https://connection.asco.org/blogs/addressing-mental-health-needs-adolescent-and-young-adult-cancer-survivors
58:44
April 15, 2021
MIB Agents OsteoBites S2 Ep 9: Jane Yanagawa, MD, “Osteosarcoma Lung Metastases”
MIB Agents OsteoBites S2 Ep 9: Jane Yanagawa, MD, “Osteosarcoma Lung Metastases” Guest Information: Jane Yanagawa, MD Associate Professor of Thoracic Surgery, UCLA David Geffen School of Medicine, Department of Surgery ... Dr. Yanagawa is a thoracic surgeon at the UCLA David Geffen School of Medicine, Department of Surgery.  She completed her residency at UCSD and her fellowship in Thoracic Surgery at Memorial Sloan-Kettering Cancer Center. ... Our panel today includes Amy Woodcheke, Physicians Assistant and Childhood Cancer Survivor.  And MIB Junior Board Members and OsteoWarriors Mia Sandino and Charlotte Murdoff.  I am your host, Ann Graham Executive Director of MIB Agents. ... Coming up next week is Sumit Gupta, MD, PhD who will be speaking on “Long Term Mental Health Outcomes in Adolescents and Young Adults with Cancer” ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites Osteosarcoma Resources:  www.MIBagents.org/contact
57:58
April 8, 2021
OsteoBites S2 Ep 8: Chand Khanna DVM, PhD, “A Comparative Approach To Metastasis: Biology and Therapy”
MIB Agents OsteoBites S2 Ep 8: Chand Khanna DVM, PhD, “A Comparative Approach To Metastasis:  Biology and Therapy” Guest Information: Chand Khanna DVM, PhD Chief Science Officer, Ethos Veterinary Health President, President of Ethos Discovery Dr. Khanna is a well known osteosarcoma expert and researcher.  He is a board-certified diplomate of the American College of Veterinary Internal Medicine (Oncology) and an honorary Diplomate of the American College Veterinary Pathology. He received a PhD in Pathobiology from the University of Minnesota and then completed a postdoctoral fellowship in the Pediatric Oncology Branch of the National Cancer Institute where he led a laboratory focused on metastasis drug discovery and was the founding director of the NCI Comparative Oncology Program. Dr. Khanna is Chief Science Officer with Ethos Veterinary Health, and President of Ethos Discovery, a nonprofit incubator of scientific innovation. ... Our panel today includes Amy Woodchecke BS, MHS, PA-C,, a childhood cancer survivor and pediatric oncology Physician’s Assistant.  I am your host, Ann Graham Executive Director of MIB Agents. ... Coming up in April with OsteoExperts Making It Better including; Jane Yanagawa, MD, Sumit Gupta, MD, PhD, Ines Lohse, PhD and Daniel Prince, MD. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites Osteosarcoma Resources:  www.MIBagents.org/contact Contact Dr. Khanna via Ethos Vet: ckhanna@ethosvet.com or Donna Reis at dreiss@ethosvet.com
59:08
April 1, 2021
OsteoBites S2 Ep7: Corrie Painter, PhD “The Osteosarcoma Project, Patient-Partnered Research Update”
MIB Agents OsteoBites S2 Ep7: Corrie Painter, PhD “The Osteosarcoma Project, Patient-Partnered Research Update” Guest Information: Corrie Painter, PhD Deputy Director, Count Me In. OSProject.org Broad Institute of MIT & Harvard Corrie Painter, PhD is the Associate Director of Count Me In and is a research scientist at the Broad Institute of MIT and Harvard.  A trained cancer researcher with a Ph.D. in biochemistry, she completed her postdoctoral work in cancer immunology, focused on melanoma. In 2010, Painter was diagnosed with angiosarcoma. She has combined her cancer advocacy and scientific background to engage with patients in order to build and carry out patient-partnered genomics studies. She is also the co-founder of Angiosarcoma Awareness Inc. ... Our panel today includes 2021 MIB Junior Board Member Shannon McCormack, 2020 Junior Board Member Ryan Kennington and Amy Woodchecke BS, MHS, PA-C,, a childhood cancer survivor and pediatric oncology Physician’s Assistant.  I am your host, Ann Graham Executive Director of MIB Agents. ... Panelists Information: Amy Woodcheke, BS, MHS, PA-C Shannon McCormack, 2021 MIB Junior Board Member & OsteoWarrior Sibling Ryan Kennington, 2020 MIB Junior Board Member & OsteoWarrior Hosted By Ann Graham, MIB AgentsExecutive Director & OsteoWarrior ... The rest of March, we will be taking a break.  April is packed with OsteoExperts Making It Better including; Chand Khanna, DVM, PhD, Jane Yanagawa, MD, Sumit Gupta, MD, PhD, Ines Lohse, PhD and Daniel Prince, MD. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites
52:40
March 5, 2021
OsteoBites S2 Ep6: Brian Van Tine, MD, PhD on “Osteosarcoma Tumor Metabolism”
MIB Agents OsteoBites S2 Ep6: Brian Van Tine, MD, PhD on “Osteosarcoma Tumor Metabolism” Guest Information: Brian Van Tine, M.D., Ph.D. Associate Professor of Medicine Associate Professor of Pediatrics Washington University in St Louis, Missouri Sarcoma Program Director Co-Director of the Adolescence and Young Adult Program Alvin J. Siteman Cancer Center. Dr. Van Tine has been the head of the Sarcoma Clinical Trials Program at Washington University for the past decade. Dr. Van Tine’s laboratory is dedicated to understanding the metabolism of sarcoma, and has recently developed a dual metabolic therapy for the treatment of complex cytogenetic sarcomas based on the exploitation of argininosuccinate synthetase 1 deficiency and glutaminase inhibition. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org … What We Do at MIB Agents: PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard .... OsteoBites is made possible by listeners like you.  Please consider donating to MIB Agents or be a Super Agent by being a monthly supporter. More info on our *New* website, mibagents.org ... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 🔗 https://www.mibagents.org
59:36
February 11, 2021
OsteoBites S2 Ep5: Robbie Majzner, MD on “Unleashing the Pediatric Immune System Against Osteosarcoma and Other Solid Tumors”
MIB Agents OsteoBites S2 Ep5: Robbie Majzner, MD on “Unleashing the Pediatric Immune System Against Osteosarcoma and Other Solid Tumors” Guest Information: Robbie Majzner, MD Assistant Professor of Pediatrics Stanford University School of Medicine ... Dr. Majzner is an Assistant Professor of Pediatrics at Stanford University School of Medicine. After graduating with a BA from Columbia University, he attended Harvard Medical School, where he developed an interest in pediatric oncology. He completed his residency at NY Presbyterian-Columbia and fellowship in pediatric hematology-oncology at Johns Hopkins and the National Cancer Institute. During his fellowship, he cared for some of the first pediatric patients to receive CD19 chimeric antigen receptor (CAR) T cells.  Witnessing the success of CAR T cells in these patients drove Dr. Majzner to the laboratory, where he focuses on developing immunotherapies for children with incurable solid tumor cancers. His laboratory work aims to generate highly efficacious CAR T cells and to find new immunotherapeutic strategies to treat pediatric cancer. ... Our panel today includes 2021 MIB Junior Board Members Charlotte Murdoff Mia Sandino, and Amy Woodchecke, a childhood cancer survivor and pediatric oncology Physician’s Assistant.  I am your host, Ann Graham President of MIB Agents. ... Panelists Information: Amy Woodcheke, BS, MHS, PA-C Charlotte Murdoff, 2021 MIB Junior Board Member & OsteoWarrior Mia Sandino, 2021 MIB Junior Board Member & OsteoWarrior Hosted By Ann Graham, MIB Agents President & OsteoWarrior ... Next week we will talk with Dr. Brian Van Tine of Washington University in St. Louis on Osteosarcoma Tumor Metabolism. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites
01:05:49
February 4, 2021
OsteoBites S3 Ep4: Lor Randall, MD, "Sarcomatology: A Trans-Disciplinary Approach"
MIB Agents OsteoBites S3 Ep4: Lor Randall, MD, Sarcomatology: A Trans-Disciplinary Approach Guest Information: R. Lor Randall, MD, FACS Professor & Chair, University of California, Davis David Linn Endowed Chair in Orthopaedic Surgery. Dr. Randall’s clinical practice and research focus on musculoskeletal surgical oncology and on building leading-edge, trans-disciplinary teams to combat rare cancers of connective tissue in children and adults.  His translational research efforts have been recognized internationally.  He is also responsible for the development of the Sarcoma Advanced Research and Clinical (SARC) Fellowship, one of the most sought-after clinical training experiences in the world. Dr. Randall has authored innumerable peer-reviewed articles, book chapters and abstracts in the field of sarcoma surgery and biology. He has received numerous national and international awards and has helped develop Adolescent and Young Adult Cancer Care Programs at Utah and UC Davis. He has served as president of the Connective Tissue Oncology Society, Musculoskeletal Tumor Society, the Association of Bone and Joint Surgeons and leads the local control subcommittee of the Bone Committee for the Children’s Oncology Group. ... Panelists Information: Amy Woodcheke, BS, MHS, PA-C Matthew Allen, 2021 MIB Junior Board Member, Gamer Agents Leadership Team Ryan Kennington, OsteoWarriors & 2020 MIB Junior Board Member Hosted By Ann Graham, OsteoWarrior & MIB Agents President ... Next week OsteoBites talks with Robbie Majzner, MD of Stanford University School of Medicine, on Unleashing the Pediatric Immune System Against Sarcoma and other Solid Tumors. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites
59:27
January 29, 2021
OsteoBites S2 Ep3: Pete Anderson, MD, PhD "Understanding Lab, Path and Scan Reports and Other Questions Answered"
MIB Agents OsteoBites S2 Ep3: Pete Anderson, MD, PhD of Cleveland Clinic Understanding Lab, Path and Scan Reports and Other Questions Answered. Guest Information: Dr. Pete Anderson is an MIB Agents Board Member and MIB Scientific Advisory Board Member.  He is a professor and practices pediatric hematology oncology at Cleveland Clinic.  He has also practiced at University of Texas MD Anderson Cancer Center, where he was section chief of non-neural solid tumors, and Mayo Clinic, where he launched the pediatric bone marrow transplant program. He received his Medical degree from Mount Sinai School of Medicine. Residency in both internal medicine and pediatrics at Duke; fellowship in pediatric hematology-oncology at University of Minnesota ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org … What We Do PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard .... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 🔗 https://www.mibagents.org
58:17
January 21, 2021
OsteoBites S2 Ep2: Alejandro Sweet Cordero, MD "Genome-Informed Targeted Therapies for Osteosarcoma"
MIB Agents OsteoBites S2 Ep2: Alejandro Sweet Cordero, MD on Genome-Informed Targeted Therapies for Osteosarcoma. Guest Information: Alejandro Sweet-Cordero, MD is a physician-scientist focused on basic and translational sarcoma biology. His interest is in mechanisms driving osteosarcoma and Ewing sarcoma progression, metastasis and therapy resistance.  They use patient-derived xenografts and direct analysis of patient tumors as tools for gene discovery. The Sweet-Cordero Lab has expertise in integrative genomic analysis and extensive experience in generating next-generation sequencing datasets for gene and network discovery using both primary tumors and human and mouse model systems. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org … What We Do PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard .... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 🔗 https://www.mibagents.org
58:54
January 14, 2021
OsteoBites S2 Ep1: Erin Murphy, Associate Professor, Radiation Oncology at Cleveland Clinic: Radiosurgery and SBRT for Sarcoma”
MIB Agents OsteoBites S2 Ep1: Erin Murphy, Associate Professor, Radiation Oncology at Cleveland Clinic:  Radiosurgery and SBRT for Sarcoma”. Guest Information: Erin S. Murphy MD is an Associate Professor in the department of radiation oncology at the Cleveland Clinic. She completed residency at the Cleveland Clinic and a fellowship in pediatric radiation oncology at St. Jude Children’s Research Hospital.  She specializes in radiotherapy and radiosurgery for brain tumors and pediatric tumors and has given many presentations and has multiple publications on these topics. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. What We Do PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard .... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 🔗 https://www.mibagents.org
58:35
January 8, 2021
OsteoBites S1 Ep28: Ryan Roberts, MD, PhD. “Dear Lungs, Stop enabling this cancer: Targeting interactions that facilitate osteosarcoma metastasis.”
MIB Agents OsteoBites S1 Ep28: Ryan Roberts, MD, PhD. “Dear Lungs, Stop enabling this cancer: Targeting interactions that facilitate osteosarcoma metastasis.” Guest Information: Ryan D. Roberts, MD, PhD Division of Hematology and Oncology-Nationwide Children’s Hospital Center for Childhood Cancer and Blood Diseases-Wexner Research Institute at Nationwide Children’s Translational Therapeutics Program-The James Comprehensive Cancer Center, Ohio State University. ... His research seeks to understand the mechanisms that support lung metastasis development in osteosarcoma. We focus on the interactions between tumor cells and lung cells, between tumor cells and immune cells, and between individual tumor cells that exhibit distinct types of behavior. By manipulating these interactions using well-tolerated agents, we hope to make the tumor cells much less comfortable in the lung—preventing metastases from forming and rendering resistant tumors treatable. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites
59:26
November 21, 2020
OsteoBites S1 Ep27: Brian Crompton, MD, “New Genomic Approaches to Understanding Osteosarcoma”
OsteoBites S1 Ep27: Brian Crompton, MD, “New Genomic Approaches to Understanding Osteosarcoma” ... Brian D. Crompton, MD Assistant Professor of Pediatrics Department of Pediatric Oncology Dana-Farber Cancer Institute ... Dr. Crompton’s research focuses on utilizing genomic and proteomic technologies to identify and validate new therapeutic targets for pediatric solid tumors and to develop non-invasive biomarkers of treatment response and resistance in these diseases. We have recently developed a new approach to study tumor genomics through liquid biopsy technologies including the profiling of circulating tumor DNA and circulating tumor cells in blood samples of patients with pediatric solid tumors. Dr. Crompton is also engaged in national efforts to study the biology of osteosarcoma through the Children’s Oncology Group studies and through patient-led research initiatives including the Count Me In project. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites
58:33
November 15, 2020
OsteoBites S1 Ep25: Sulagna Banerjee, PhD, “Modeling Osteosarcoma in Mice”
MIB Agents OsteoBites S1 Ep25: Sulagna Banerjee, PhD, “Modeling Osteosarcoma in Mice”   Guest Information: *Sulagna Banerjee, PhD Research Scientist, University of Miami Health System Sulagna Banerjee Laboratory Associate Professor, University of Miami’s Miller School of Medicine.   ... Hosted By Ann Graham, OsteoWarrior & MIB Agents President   ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Next week, OsteoBites welcome Dr. Jin-Ah Kim of Children’s Cancer Therapy Development Institute.  Dr. Kim will be speaking about “Reversing Checkpoint Adaptation: Making Osteosarcoma Treatments Work Better.”    ... Register: https://bit.ly/MIBobites
52:59
October 16, 2020
OsteoBites S1 Ep24: Andy Woods & Charles Keller, MD: "Legacy Autopsy”
MIB Agents OsteoBites S1 Ep24: Andy Woods & Charles Keller, MD: "Legacy Autopsy” Guest Information: *Andy Woods, BS Senior Research Scientist & Childhood Cancer Dad Children’s Cancer Therapy Development Institute (cc-TDI) *Charles Keller, MD Scientific Director Children’s Cancer Therapy Development Institute (cc-TDI) ... Panelists Information: Shannon McCormick, MIB Ambassador Agent, OsteoWarrior Sibling Amanda Levine, OsteoWarrior, Patient Advocate Hosted By Ann Graham, OsteoWarrior & MIB Agents President ... Next week OsteoBites takes a break. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites
59:46
September 25, 2020
Lauren: Osteosarcoma Survivor, Sibling of OsteoAngel and MIB Jr. Board Member
Lauren: Osteosarcoma Survivor, Sibling of OsteoAngel and MIB Jr. Board Member Each week we feature a survivor of Osteosarcoma on #SurvivorSaturday. This week, we shared a video from our annual MIB FACTOR 2020 Osteosarcoma Conference.  Lauren closed out our conference by sharing hers and her family's story of fighting this disease. Lauren, an MIB Agent Jr Board Member, had us crying, cheering and on our feet clapping at FACTOR 20.  Her story of survivorship, loss, gratitude and grace is inspiring and humbling. ... More Hope: https://bit.ly/MIBhope ... Video Production: Maggie Scanlon 
09:28
September 21, 2020
OsteoBites S1 Ep23: Brian Flesner, DVM, MS, DACVIM: "Adjuvant Chemotherapy for Canine Osteosarcoma ”
MIB Agents OsteoBites S1 Ep23: Brian Flesner, DVM, MS, DACVIM: "Adjuvant Chemotherapy for Canine Osteosarcoma” ... Guest Information: *Brian Flesner, DVM, MS, DACVIM American College of Veterinary Internal Medicine (ACVIM) Assistant Professor of Oncology College of Veterinary Medicine at the University of Missouri ... In addition to studying #osteosarcoma, Dr. Flesner’s research interests include chemotherapy mechanisms of action and toxicity, cancer-induced pain, and novel chemotherapeutic approaches to combat aggressive neoplasms. Extensively involved in the vibrant clinical trials service at the MU Veterinary Health Center. The trials service sees hundreds of patients annually; notably, 70 dogs with osteosarcoma were enrolled in osteosarcoma specific clinical trials in the past four years. Dr. Flesner is currently site principal-investigator for several ongoing osteosarcoma studies, including three near completion National Cancer Institute COTC nationwide trials.   ... Panelists Information: *Charlotte Murdoff, OsteoWarrior *Casey Crossan, MIB Agents Development & Operations Chief *Hosted By Ann Graham, OsteoWarrior & MIB Agents President ... Next week on OsteoBites our guest will be Charles Keller, MD and Andy Wood of cc-TDI speaking on "Legacy Autopsy Gifts: The After-LIfe Gift of Tissue".    ...   MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites
58:38
September 18, 2020
OsteoBites S1 Ep22: Reed: "Moffitt Osteosarcoma Research Approach”
MIB Agents OsteoBites S1 Ep22: Damon Reed, MD: "Moffitt Osteosarcoma Research Approach ” Guest Information: *Damon Reed, MD Moffitt Cancer Center Director, Adolescent Young Adult Program Interim Chair of the Dept of of Individualized Cancer Mgmt Asst Professor of Pediatrics, University of South Florida. MIB Agents Scientific Advisory Team Panelists Information: Amanda Levine, OsteoWarrior & Patient Advocate Ryan Kennington, OsteoWarriors & MIB Junior Board Member Hosted By Ann Graham, OsteoWarrior & MIB Agents President ... Next week OsteoBites talks with Dr. Brian Flesner of University of Missouri about Adjuvant Chemotherapy for Canine Osteosarcoma, and September 24th Dr. Charles Keller and Andy Woods talk about the After-Life Gift of Legacy Tissue Donation. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites
58:11
September 10, 2020
OsteoBites S1 Ep21: Kurt Weiss, MD, A Day In the Life of a Musculoskeletal Oncologist
MIB Agents OsteoBites S1 Ep21: Weiss: "A Day In the Life of a Musculoskeletal Oncologist”    ... Guest Information: *Kurt Weiss, MD OsteoWarrior Associate Professor University of Pittsburgh, School of Medicine   Department of Orthopaedic Surgery, Division of Musculoskeletal Oncology Vice Chair of Translational Research Director Musculoskeletal Oncology Laboratory   Panelists are:   *Maeve Smart OsteoWarrior & MIB Junior Board Member *Ryan Kennington Hosted By Ann Graham OsteoWarrior & MIB Junior Board Member *Hosted by: Ann Graham, OsteoWarrior & MIB Agents President ... Next week OsteoBites takes a break in honor of Labor Day.   Childhood Cancer Awareness Month, also known as September, has three great speakers starting on September 10th with Dr. Damon Reed, September 17th with Dr. Brian Flesner and September 24th Dr. Charles Keller.    ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Register: https://bit.ly/MIBobites
57:36
August 28, 2020
OsteoBites S1 Ep20: Correlative Science Leading to Active and Emerging Clinical Trials for #Osteosarcoma
MIB Agents OsteoBites S1 Ep20: Correlative Science Leading to Active and Emerging Clinical Trials for #Osteosarcoma   ... Guest Information: *Richard Gorlick, MD Division Head, Dept Chair and Professor Pediatrics Director of the Pediatric Sarcoma Research Lab   The University of Texas, MD Anderson Cancer Center   *J. Andrew Livingston, MD Assistant Professor, Department of Sarcoma Medical Oncology Department of Pediatrics Co-leader for the MDACC Adolescent and Young Adult Program   University of Texas MD Anderson Cancer Center   *Sajad Khazal, MB. ChB. Assistant Professor, Department of Pediatrics Patient Care Division of Pediatrics The University of Texas MD Anderson Cancer Center Panelists: *Charlotte Murdoff OsteoWarrior & MIB Fund Holder  *Ryan Kennington OsteoWarrior & MIB Agents Junior Board Member *Amanda Levine OsteoWarrior & Patient Advocate Hosted By Ann Graham, MIB Agents President    ... Register for next week when we will be speaking with:  Kurt Weiss, MD Fellow for Innovative Cancer Research Associate Professor, University of Pittsburgh School of Medicine Department of Orthopaedic Surgery/Musculoskeletal Oncology Vice Chair of Translational Research and Director of the Musculoskeletal Oncology Laboratory  Baylor College of Medicine ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ...
01:02:21
August 21, 2020
OsteoBites S1 Ep19: Modeling & Targeting MYC-Driven Osteosarcoma
MIB Agents OsteoBites S1 Ep19: Modeling & Targeting MYC-Driven #Osteosarcoma with Jason Yustein, MD, PhD Guest Information: Jason Yustein, MD, PhD Texas Children’s Hospital Associate Professor, Department of PediatricsHematology/Oncology Baylor College of Medicine … Hosted by Ann Graham MIB Agents Founder & President. … Register for next week when we will be speaking with Richard Gorlick, MD Division Head and Department Chair University of Texas, MD Anderson Cancer Center “Correlative Science Leading to Active and Emerging Clinical Trials”. Register: https://bit.ly/MIBobites ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ... Osteosarcoma, Bone Cancer, Sarcoma, Pediatric Cancer, Childhood Cancer, Cancer, Cancer Research
32:45
August 14, 2020
OsteoBites S1 Ep18: Coping Through Cancer: Tips for Parents & Caregivers
MIB Agents OsteoBites S1 Ep18: Coping Through Cancer: Tips for Parents & Caregivers   ... Guest Information: *Lori Wiener, PhD Co-Director, Behavioral Health Core   Director, Psychosocial Support and Research Program Pediatric Oncology Branch, Center for Cancer Research National Cancer Institute & National Institutes of Health    *Amanda Thompson, PhD   Chief, Pediatric Psychology Life with Cancer Inova Schar Cancer Institute Inova Health System …  Hosted by Ann Graham MIB Agents Founder & President. … Register for next week when we will be speaking with Jason Yustein, MD, PhD of  Texas Children’s Hospital Associate Professor, Department of PediatricsHematology/Oncology Baylor College of Medicine On “Modeling and Targeting MYC-Driven OS”.  Register: https://bit.ly/MIBobites ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org ...
58:29
August 10, 2020
OsteoBites S1 Ep17: The #Osteosarcoma Patient Decision Aid for Surgical Options in the Lower Extremity
MIB Agents OsteoBites S1 Ep17: The Osteosarcoma Patient Decision Aid for Surgical Options in the Lower Extremity with Janet Panoch, PhD of Indiana University ... Guest Information: *Janet Panoch, PhD Assistant Research Professor Department of Pediatrics Indiana University School of Medicine ... Panelists: Sloane Dyer, MIB Agents Jr. Board Member & OsteoWarrior Maeve Smart, MIB Agents Jr. Board Member & OsteoWarrior Amanda Braunfeld Levine, OsteoWarrior and the founder FaceBook Group for #osteosarcoma and a Patient Advocate Hosted by Ann Graham MIB Agents Founder & President ... Register for next week when we will be speaking with Dr. Lori Weiner, co-director of the Behavioral Health Core and Head of the Psychosocial Support and Research Program of the NCI’s Center for Cancer Research. AND Dr. Amanda Thompson, Chief of Pediatric Psychology at INOVA Life With Cancer Program.“Coping Through Cancer” ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at MIBagents.org. ... Register For OsteoBites: https://bit.ly/MIBobites 
51:44
July 30, 2020
OsteoBites S1 Ep16: Peter Anderson, MD, PhD on Making It Better for OS Patients
MIB Agents OsteoBites S1 Ep16: Peter Anderson, MD, PhD on Making It Better for Osteosarcoma Patients ... Guest Information: Peter Anderson, MD, PhD Pediatric Hematology Oncology and Blood and Marrow Transplantation Cleveland Clinic Cleveland, Ohio ... Panelists: Maeve Smart, MIB Agents Jr. Board Member, OsteoWarrior Sloane Dyer, MIB Agents Jr. Board Member, OsteoWarrior Amanda Braunfeld Levine, OsteoWarrior, Founder of FaceBook Group for #osteosarcoma and a Patient Advocate Hosted by Ann Graham MIB Agents Founder & President. … Register for next week when we will be speaking with Dr. Janet Panoch of Indiana University on the Osteosarcoma Patient Decision Aid for Surgical Options in the Lower Extremity. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org Register HERE: https://bit.ly/MIBpete
58:37
July 23, 2020
OsteoBites S1 Ep15: Survivorship Care Planning with David Poplack, MD and Ellen Shohet, RN
Survivorship Care Planning with David Poplack, MD and Ellen Shohet, RN with Passport For Care, an interactive website that addresses the need to provide long-term survivors of #ChildhoodCancer and their caregivers with screening guidelines and resources individualized to the survivor’s treatment history.   ... Guest Information: *Ellen Shohet, MN, RN Nurse Navigator, Passport For Care Baylor College of Medicine Texas Children's Hospital   *David Poplack, MD Director of Texas Children's Hospital Cancer and Hematology Centers for 25 years. Associate Director of the Cancer and Hematology Centers Director of Global Hematology-Oncology Pediatric Excellence (HOPE) Developer of the Passport for Care®. ... Panelists: Alexis Johnson, OsteoWarrior MIB Agents Jr. Board Member MIB Mission Commander  Amanda Braunfeld Levine, OsteoWarrior Founder- FaceBook Group for #osteosarcoma Patient Advocate  Hosted by Ann Graham MIB Agents Founder & President. … Register for next week when Peter Anderson, MD, PhD, Pediatric Hematology Oncology at Cleveland Clinic shares Osteosarcoma information and answers general osteosarcoma questions. ... MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
59:58
July 17, 2020
OsteoBites S1 Ep14 Katie Janeway, MD, NEW Osteosarcoma Clinical Trial
NEW CLINICAL TRIAL FOR #OSTEOSARCOMA ANNOUNCED!  MIB Agents Osteosarcoma Webinar Series:  Katherine A. Janeway, MD, and Suzanne Forrest, MD discuss the opening of a new clinical trial for osteosarcoma, funded by Osteosarcoma Institute.  Updates on the OSProject as well!  TRIAL LINK ... Guest Information: *Katherine A. Janeway, MD, MMSc‬ ‪Associate Professor of Pediatrics, HMX - Harvard Medical School ‪ Senior Physician, Dana-Farber Cancer Institute/Boston Children's Hospitals Cancer & Blood Disorders Center‬ ‪ Director, Clinical Genomics, Dana-Farber‬ Cancer Institute *Suzanne Forrest, MD Instructor of Pediatrics, Harvard Medical School Pediatric Hematology/Oncology, Dana-Farber Cancer Institute, Boston Children's Cancer & Blood Disorders ... All OsteoWarrior Panelists are; *Maeve Smart is an MIB Agents Jr. Board Member and and OsteoWarrior *Alexis Johnson is an MIB Agents Jr. Board Member and MIB Mission Commander *Amanda Braunfeld Levine is a Patient Advocate and Founder/Moderator of Osteosarcoma Support FaceBook Page ... Hosted by Ann Graham, MIB Agents Founder & President. … MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information at www.mibagents.org ... Register for next week when Ellen Shobet, RN Nurse Navigator at Baylor College of Medicine and Texas Children's Hospital is here with David Poplack, MD, Director of Global Hematology-Oncology Pediatric Excellence (HOPE) and Associate Director of Texas Children’s Cancer and Hematology Centers to talk about Passport for Care.  Register: https://bit.ly/MIBobites Less
48:22
July 10, 2020
OsteoBites S1 Ep12: John Healey, MD, Precision Surgery for Osteosarcoma
MIB Agents #Osteosarcoma Alliance Webinar Series:  John Healey, MD, FACS talks with us about Precision Surgery for osteosarcoma and answers questions from callers and panelists.  This session is powerful, informative and even entertaining.  We are so grateful for Dr. Healey's expertise and care of this community of patients.  He is a brilliant and careful surgeon and an important part of MIB Agents. ... Guest Information: John Healey, MD, FACS Chief of Orthopedic Surgery Memorial Sloan Kettering Cancer Center MIB Agents Board of Directors MIB Agents Scientific Advisory Team Contributor, "Osteosarcoma: From Our Family to Yours" Book ... Panelists: Lauren Ramer is an MIB Agents Jr. Board Member, OsteoWarrior and sibling to OsteoAngel Brother, Brent. Andrew Bisaga is an MIB Agents Jr. Board Member and OsteoWarrior Amanda Levine is the founder and manager of the Closed FaceBook Group for osteosarcoma and a Patient Advocate Liz Vallejo is MIB Agents Programs Chief and Mom to OsteoAngel Ian ... Hosted by Ann Graham, MIB Agents Founder & President. … MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information at www.mibagents.org ... Register for next week when Katie Janeway, MD, Professor of Harvard Medical School and Center Director at Dana Farber/Boston Children's Blood Disorders Center talks with us about a Clinical Trial Funded by Osteosarcoma Institute. MIBagents.org Register: https://bit.ly/MIBobites
01:12:20
July 2, 2020
OsteoBites S1 Ep11: Alanna Church, MD and Christina Ip-Toma, MIB Testing & Research Directory
MIB Agents Osteosarcoma Webinar Series:  Alanna Church, MD of Boston Children's and Harvard Medical School and Christina Ip-Toma MIB Testing  Research Directory Lead talk about navigating the Testing & Research Directory to help inform a personal treatment plan or to inform research. Christina Ip-Toma, MIB OsteoWarrior Parent and Alanna Church, MD Pathologist at Dana Farber & Harvard Medical School worked together with Matteo Trucco, MD, Katie Janeway, MD, Alejandro Sweet-Cordero, MD, Will Parsons, MD, Joshua Schiffman, MD, Ines Lohse, PhD and Al Cornelius, MD to bring this important document to you as an essential decision-making document. OsteoParents Karen Davis and Caroline Rothermel Adams contributed early work to bring about this work. ... Guest Information: Alanna Church, MD is the Associate Director for Molecular Pediatric Pathology Laboratory (LaMPP) Staff Pathologist, Department of Pathology Boston Children's Hospital Assistant Professor of Pathology Harvard Medical School Christina Ip-Toma MIB Agents Testing & Research Directory OsteoWarrior Mom ... Panelists: Maeve Smart is an MIB Agents Jr. Board Member and and OsteoWarrior Amanda Levine is the founder and manager of the Closed FaceBook Group for osteosarcoma and a  Patient Advocate ... Hosted by Ann Graham, MIB Agents Founder & President. … MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information at www.mibagents.org ... #Osteosarcoma #BoneCancer Register for next week when John Healey, MD, Chief of Orthopedic Surgery at Memorial Sloan Kettering Cancer Center and MIB Agent Board of Director talks with us about Precision Surgery for Osteosarcoma. MIBagents.org Register: https://bit.ly/MIBobites
50:56
June 19, 2020
OsteoBites S1 Ep10: Simon Holland and Elly App
MIB Agents Osteosarcoma Webinar Series:  Simon Holland, Co-Founder of Elly Health shares Elly Health  -an app that provides support and comfort for those in treatment for cancer ... Guest Information: *Simon Holland spent his childhood between Peru, Australia and Spain, and was exposed to a diverse array of people, places and culture. Bringing these eclectic experiences into adulthood, he studied Entrepreneurship at RMIT in Melbourne.  Simon has applied his knowledge of design, strategic thinking and defining a clear purpose to over 50 startups. He believes the entrepreneurial struggle is an opportunity for innovative thinking. He used this passion to help fledgling startups grow and find a product-market fit.  Simon co-founded HotDoc, Australia’s largest patient engagement platform used by almost 5 millions patients, as well as Vivi which is a screen mirroring solution for education.  In 2019 Simon moved to Los Angeles to co-found Elly, an empathetic audio companion for patients living with a chronic disease. ... OsteoBites Panelists are; *Liz Vallejo is MIB Agents Programs Chief and OsteoWarrior Mom to Ian. *Maeve Smart is an MIB Agents Jr. Board Member and and OsteoWarrior *Lauren Ramer is an MIB Agents Jr. Board Member and OsteoWarrior who has also contributed content to the Elly App. ... Hosted by Ann Graham, MIB Agents Founder & President. … MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information at www.mibagents.org ... #Osteosarcoma #BoneCancer #Elly Register for next week when Christina Ip-Toma of MIB Agents and Dr. Alanna Church of Dana Farber Cancer Institute and Professor at Harvard Medical School talk with us about the MIB Testing and Research Directory -a guide to testing and research options to either help inform a personal treatment plan and/or contribute to general osteosarcoma research. MIBagents.org Register: https://bit.ly/MIBobites
40:25
June 12, 2020
OsteoBites S1 Ep9: Amputee Coalition
MIB Agents Osteosarcoma Webinar Series:  Tonya Osborne-Simpson and Nicole Gross of Amputee Coalition share programs and resources and discuss the partnership with MIB Agents. ... Guest Information: *Tonya Osborne-Simpson, Director of Support & Outreach and Certified Master Trainer oversees the Peer Support department and the National Limb Loss Resource Center. *Nicole Gross is the Peer Support Programs Manager. Nicole joined the Amputee Coalition in January 2018 with both personal and professional experience in supporting the limb loss and limb difference community as a former adaptive swim and para-triathlon coach and 2013 Boston Marathon Bombing survivor. After her traumatic above knee amputation, Nicole’s sister and Mom became Certified Peer Visitors to help others along their journey. As Peer Support Programs Manager, Nicole oversees the Amputee Coalition’s nationally recognized Certified Peer Visitor Program, Support Group Network, and Hospital Partnership Program. She is a former University of Tennessee Lady Vol Swimmer and has competed in the Ironman World Championships. ... OsteoBites Panelists are; *Amanda Braunfeld Levine of the closed FB group "Bone Cancer Support...for lives touched by Osteosarcoma & Ewing Sarcoma" *Maureen Smart, LCSW and MIB Peer Training Leader *Liz Vallejo, MIB Agents Programs Chief ... Hosted by Ann Graham, MIB Agents Founder & President. … MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information at www.mibagents.org
52:02
June 4, 2020
OsteoBites S1 Ep8: Osteosarcoma Research, Joshua Schiffman, MD
MIB Agents Osteosarcoma Webinar Series: Dr. Joshua Schiffman shares an update on his osteosarcoma research, funded by MIB Agents: "EP53 Loaded Nanoparticles for Osteosarcoma".   After a presentation on this research, Dr. Schiffman answers questions from attendees. ... Guest Information: Joshua Schiffman, MD Medical Director, Family Cancer Assessment Clinic Professor of Pediatrics (Hematology/Oncology) Adjunct Professor of Oncological Sciences Investigator, Huntsman Cancer Institute University of Utah ... OsteoBites Panelist is Amanda Braunfeld Levine of the closed FB group "Bone Cancer Support...for lives touched by Osteosarcoma & Ewing Sarcoma". Hosted by Ann Graham, President of MIB Agents. MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
45:25
May 28, 2020
OsteoBites S1 Ep7: Osteosarcoma Research, Matteo Trucco, MD
MIB Agents Osteosarcoma Webinar Series:  Dr. Matteo Trucco shares an update on his osteosarcoma research, funded by MIB Agents:  "Disulfiram to Overcome Chemo Resistance".  After a  presentation on this research, Dr. Trucco answers questions from attendees. ... Guest Information: Matteo Trucco, MD Director Children's Cancer Innovative Therapy Program Associate Staff, Peds Hematology-Oncology & BMT    Cleveland Clinic Children's   ... OsteoBites Panelists are Amanda Braunfeld Levine of the closed FB group "Bone Cancer Support...for lives touched by Osteosarcoma & Ewing Sarcoma" and Florencia Pistritto of the Facebook Group "Osteosarcoma and Ewing's Sarcoma Support Group" and Liz Vallejo, MIB Agents Program Chief. Hosted by Ann Graham, President of MIB Agents.  MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information at www.mibagents.org
46:55
May 23, 2020
OsteoBites S1 Ep6: Osteosarcoma Research, J. Andrew Livingston, MD
 MIB Agents Osteosarcoma Webinar Series OsteoBites  Dr. Andrew Livingston shares an update on his osteosarcoma research, funded by MIB Agents:  "CD73 The Next Immunotherapy Target for OS".  After a  presentation on this research, Dr. Livingston answers questions from attendees.  ...  Guest Information: J. Andrew Livingston, MD Assistant Professor, Department of Sarcoma Medical Oncology Department of Pediatrics Co-leader for the MDACC Adolescent and Young Adult Program   University of Texas MD Anderson Cancer Center ... OsteoBites Panelists are Amanda Braunfeld Levine of the closed FB group "Bone Cancer Support...for lives touched by Osteosarcoma & Ewing Sarcoma" and Florencia Pistritto of the Facebook Group "Osteosarcoma and Ewing's Sarcoma Support Group".  Hosted by Ann Graham, President of MIB Agents.   MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information/Help us fund research at www.mibagents.org
40:15
May 14, 2020
OsteoBites S1 Ep5: Osteosarcoma Research, Alex Huang, MD, PhD of UH Rainbow Babies & Children's & CWRU
MIB Agents Osteosarcoma Webinar Series:  Dr. Alex Huang shares an update on his osteosarcoma research, funded by MIB Agents:  "Conditioning the Immune Environment for Effective Therapies for Metastatic OS".  After a  presentation on this research, Dr. Huang answers questions from attendees. ... Guest Information: Alex Huang, MD, PhD Website: www.huanglab.com Theresa G. & Stuart F. Kline Family Foundation Chair in Pediatric Oncology Professor of Pediatrics, Pathology, Biomedical Engineering and General Medical Sciences Case Western Reserve University School of Medicine Director, Pediatric Hematology-Oncology Fellowship Program UH Rainbow Babies & Children's Hospital   ... OsteoBites Panelists are Amanda Braunfeld Levine of the closed FB group "Bone Cancer Support...for lives touched by Osteosarcoma & Ewing Sarcoma" and Florencia Pistritto of the Facebook Group "Osteosarcoma and Ewing's Sarcoma Support Group".  Hosted by Ann Graham, President of MIB Agents.  MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information at www.mibagents.org
52:36
May 8, 2020
OsteoBites S1 EP2: Osteosarcoma Q&A with Matteo Trucco, MD of Cleveland Clinic
MIB Agents OsteoBites welcomes Matteo Trucco, MD of Cleveland Clinic.  He answers general osteosarcoma questions. ... Guest Information: Matteo Trucco, MD Director Children's Cancer Innovative Therapy Program Associate Staff, Peds Hematology-Oncology & BMT    Cleveland Clinic Children's    ... OsteoBites Panelists are Amanda Braunfeld Levine of the closed FB group "Bone Cancer Support...for lives touched by Osteosarcoma & Ewing Sarcoma" and Florencia Pistritto of the Facebook Group "Osteosarcoma and Ewing's Sarcoma Support Group".  Hosted by Ann Graham, President of MIB Agents.   ... MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information at www.mibagents.org
39:02
May 6, 2020
OsteoBites S1 Ep4: Upfront Surgery for Osteosarcoma, David Loeb, MD, PhD & Matteo Trucco, MD
MIB Agents Osteosarcoma Webinar Series:  Grab a snack and sit down with Dr. Loeb and Dr. Trucco to talk about and vote on a possible clinical trial on Upfront Surgery for Osteosarcoma. YOU can help inform osteosarcoma research!  After the presentation on this research, Dr. Loeb & Dr. Trucco answer questions from attendees. ... Guest Information: David Loeb, MD, PhD Chief, Division of Pediatric Hematology, Oncology, and Marrow & Blood Cell Transplantation Children's Hospital at Montefiore Professor, Pediatrics Developmental and Molecular Biology Albert Einstein College of Medicine   Matteo Trucco, MD Director Children's Cancer Innovative Therapy Program Associate Staff, Peds Hematology-Oncology & BMT    Cleveland Clinic Children's   ... OsteoBites Panelists are Amanda Braunfeld Levine of the closed FB group "Bone Cancer Support...for lives touched by Osteosarcoma & Ewing Sarcoma" and Florencia Pistritto of the Facebook Group "Osteosarcoma and Ewing's Sarcoma Support Group".  Hosted by Ann Graham, President of MIB Agents.  MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information at www.mibagents.org  PLEASE TAKE THIS SURVEY TO HELP INFORM TRIAL CONCEPT: bit.ly/MIBobSURG
49:33
May 2, 2020
OsteoBites: S1, EP3 Osteosarcoma Institute with Lee Helman, MD & Joyce Schaffer, RN
MIB Agents Osteosarcoma Webinar Series:  Lee Helman, MD of the Osteosarcoma Institute and Joyce Shaffer, RN of Osteosarcoma Institute, (OS Institute).  The OS Institute is committed to osteosarcoma research and service to the OS community.  Dr. Helman and Joyce talk about the incredible free resource, the Osteosarcoma Hotline and osteosarcoma in general. OSTEOSARCOMA HOTLINE: 833-801-3435 ... Guest Information: Lee Helman, MD Director, Osteosarcoma Institute (Osinst.org) Adjunct Clinical Professor of Pediatrics   Cancer and Blood Disease Institute CHLA Keck School of Medicine, USC ... OsteoBites Panelists are Amanda Braunfeld Levine of the closed FB group "Bone Cancer Support...for lives touched by Osteosarcoma & Ewing Sarcoma" and Florencia Pistritto of the Facebook Group "Osteosarcoma and Ewing's Sarcoma Support Group".  Hosted by Ann Graham, President of MIB Agents.   ... MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.  More information at www.mibagents.org
46:12
April 27, 2020